According to the NHS, symptoms may involve your ability to pay attention to things, having high energy, or being unable to ...
Attention-Deficit Hyperactivity Disorder, or ADHD, affects tens of millions of people in the U.S.About one in nine children ...
Though different people experience attention deficit hyperactivity disorder (ADHD) in different ways, it is something that can significantly disrupt a person's life. Whether in the classroom, ...
Health and well-being don't jump to mind when discussing adult ADHD, and neither do poor health, suffering, disability, and ...
Kids often squirm, fidget, talk too much, or don’t want to take turns. It’s not unusual for any kid to have trouble paying attention sometimes. But for almost 10% of kids with ADHD (attention deficit ...
Attention-deficit/hyperactivity disorder in childhood is associated with a high probability of multimorbidity and health-related disability in midlife, a new cohort study shows.
With an expiration date still more than a year away, here's what the latest details reveal.
FDA fast tracks ADHD drug centanafadine, targeting approval by July 24 for treatment across all age groups, based on phase 3 trial results.
Two-thirds of social media content about attention deficit hyperactivity disorder (ADHD) is sometimes medically inaccurate, yet referral rates for the condition have risen at almost identical rates to ...
In a recent study published in Scientific Reports, researchers assessed the importance of attention-deficit hyperactivity disorder (ADHD) features as a predictor of internalizing problems. Study: ...
More and more women are being diagnosed with ADHD, a condition that was historically identified in children and specifically boys. The diagnosis is complicated, but for the most part, validating and ...
The FDA has started a priority review of Otsuka Pharma's triple-acting drug for attention-deficit hyperactivity disorder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results